BHV Partners closes first round of investment with €500,000

Comunicació,

BHV Partners, the first venture builder in the healthcare sector in southern Europe, has closed a €500,000 round of investment with participation from private investors, executives and science and medical professionals.

With just over a year in the business, BHV Partners has already invested in three start-ups: Aimentia, an artificial intelligence platform for mental health; Nela Biodynamics, which specialises in designing and developing orthopaedic devices; and Biel Glasses, which develops smart glasses.“We aim to have 30 innovative projects in our portfolio by 2025,” explained Marta Príncep, managing partner of BHV Partners, to La Vanguardia.

The venture builder has also reached collaboration agreements with the Inveniam Group, a company with experience in technology transfer, fundraising and access to public funds; and with Anquor Corporate Finance, which specialises in mergers and acquisitions in the life sciences sector.

BHV Partners has offices at the Barcelona Science Park and in San Francisco, and is a member of CataloniaBio & HealthTech.

Photo: Marta Príncep, managing partner of BHV Partners - © BHV Partners

Comments


To comment, please login or create an account
Modify cookies